4/A//SEC Filing
SOFINNOVA CAPITAL VI FCPR 4/A
Accession 0001104659-20-086507
CIK 0001760542other
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 5:07 PM ET
Size
7.3 KB
Accession
0001104659-20-086507
Insider Transaction Report
Form 4/AAmended
SOFINNOVA CAPITAL VI FCPR
10% Owner
Transactions
- Sale
Common Stock
2020-06-29$11.78/sh−3,280$38,628→ 3,960,574 total
Sofinnova Partners SAS
10% Owner
Transactions
- Sale
Common Stock
2020-06-29$11.78/sh−3,280$38,628→ 3,960,574 total
Footnotes (3)
- [F1]Shares sold pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.75 to $11.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.
Documents
Issuer
HOOKIPA Pharma Inc.
CIK 0001760542
Entity typeother
IncorporatedXX
Related Parties
1- filerCIK 0001441261
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 5:07 PM ET
- Size
- 7.3 KB